
Pityriasis Rubra PilarisTreatment With Folic Acid Antagonists
JACK BROWN, MD;
HAROLD O. PERRY, MD
Arch Dermatol. 1966;94(5):636-638.
Abstract
Four patients with pityriasis rubra pilaris were treated with the oral form of folic acid antagonists (aminopterin and methotrexate) for an average duration of 12 months. Marked clinical improvement was noted in all four patients. Two patients have discontinued therapy for periods of 24 and 7 months and have not had a recurrence of their disease.
The pharmacology of folic acid antagonists and the rationale for their use in the treatment of pityriasis rubra pilaris are briefly discussed.
Author Affiliations
ROCHESTER, MINN
From the Section of Dermatology, Mayo Clinic and Mayo Foundation (Dr. Perry), and Mayo Graduate School of Medicine, University of Minnesota (Dr. Brown), Rochester.
Footnotes
Accepted for publication Aug 24, 1966.
Reprint requests to 200 First St SW, Rochester, Minn 55901 (Dr. Brown).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pityriasis Rubra Pilaris Responding to Aminonicotinamide
Binnick
Arch Dermatol 1978;114:1348-1349.
ABSTRACT
Immunosuppressive and Cytotoxic Drugs in Dermatology
Dantzig
Arch Dermatol 1974;110:393-406.
ABSTRACT
Pityriasis Rubra Pilaris: Prolonged Treatment With Methotrexate
Knowles and Chernosky
Arch Dermatol 1970;102:603-612.
ABSTRACT
Pityriasis Rubra Pilaris: A Follow-up Study of 57 Patients
Davidson et al.
Arch Dermatol 1969;100:175-178.
ABSTRACT
Pityriasis Rubra Pilaris: Report of a Case and Analysis of the Literature
Gross et al.
Arch Dermatol 1969;99:710-716.
ABSTRACT
|